Biotech’s Iron Lady: The Story of Dr. Zanganeh

Now in the final phase of clinical trials, ivonescimab could reshape cancer treatment and redefine Zanganeh’s legacy. Driven by her own battle with cancer and a passion for rapid decision-making in drug development, she remains committed to improving patient outcomes. “We move fast because we want to help all these patients,” she told Forbes. Her journey, from revolution-stricken Iran to biotech stardom, is nothing short of inspirational.